Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Case Reports

Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation

Abstract

A case of acute myelogenous leukemia with a t(8;21) translocation relapsed 5 months after allogeneic bone marrow transplantation (allo-BMT). After chemotherapy-induced hematologic remission, the patient received donor lymphocyte infusions (DLI); 4.9 × 108/kg T cells were infused. After DLI, she achieved molecular CR for the first time after allo-BMT, which lasted for 40 months. However, she suffered from grade III acute GVHD of the skin and the liver. Hepatic GVHD was sustained and resulted in fatal outcome. The case demonstrates that DLI is a double-edged sword. Further study is necessary before DLI can be considered to be a beneficial therapy for acute leukemia. Bone Marrow Transplantation (2000) 26, 809–810.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Kumar L . Leukemia: management of relapse after allogeneic bone marrow transplantation J Clin Oncol 1994 12: 1710–1717

    Article  CAS  Google Scholar 

  2. Kishi K, Takahashi S, Gondo H et al. Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes Bone Marrow Transplant 1997 19: 461–466

    Article  CAS  Google Scholar 

  3. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of GVL responses from GVHD Blood 1995 86: 1261–1268

    CAS  PubMed  Google Scholar 

  4. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients Blood 1995 86: 2041–2050

    CAS  Google Scholar 

  5. Kantarjian HM, O’Brien S, Anderlini P, Talpaz M . Treatment of chronic myelogenous leukemia: current status and investigational options Blood 1996 87: 3069–3081

    CAS  PubMed  Google Scholar 

  6. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J Clin Oncol 1997 15: 433–444

    Article  Google Scholar 

  7. Buzyn-Veil A, Belanger C, Audat F et al. Sustained complete cytologic and molecular remission induced by donor leukocyte infusions alone in an acute myeloblastic leukemia in relapse after bone marrow transplantation Br J Haematol 1996 92: 423–425

    Article  CAS  Google Scholar 

  8. Fores R, Diez-Martin JL, Briz M et al. Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 439–441

    CAS  PubMed  Google Scholar 

  9. Alessandro EP, Bernasconi P, Caldera D et al. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation Bone Marrow Transplant 1999 23: 607–612

    Article  Google Scholar 

  10. Azuno Y, Kaneko T, Nishimura M et al. Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia Bone Marrow Transplant 1996 18: 257–259

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Prof Shintaro Shiobara for encouraging us to publish our work and to Ms Kuniko Numata for her assistance in preparing the manuscript.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Imoto, S., Murayama, T., Gomyo, H. et al. Long-term molecular remission induced by donor lymphocyte infusions for recurrent acute myeloblastic leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 26, 809–810 (2000). https://doi.org/10.1038/sj.bmt.1702602

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702602

Keywords

This article is cited by

Search

Quick links